On pharmacological potential to modify human memory

This paper identifies the downsides and potential justifications of pharmaceutical memory alteration, a topic sparking many controversies. Recent advancements in psychiatry show the possibility of modifying and suppressing traumatic memories, which could be applicable primarily in PTSD patients. As conventional forms of treatment often fail or result in relapse, pharmacological solutions could offer a viable alternative. However, it raises profound bioethical concerns, mainly in the aspects of identity, authenticity, and moral responsibility with the risk of the distortion of testimonies or tampering with the historical truth. The discussion engages with the philosophical tension between the necessity of suffering as a formative human experience and the imperative to alleviate debilitating distress. PTSD not only disrupts personal well-being, but also significantly impacts interpersonal relationships, social functioning, and long-term psychological stability. This essay argues that memory modification should be the last resort, employed only when other treatments have been proven ineffective. The debate highlights the need for a balanced approach that prioritizes patient well-being while respecting ethical constraints in neuroenhancement.